Add like
Add dislike
Add to saved papers

Assessing groundwater vulnerability potential using modified DRASTIC in Ajabshir Plain, NW of Iran.

The vulnerability of groundwater as the primary source of water for human survival should be assessed for the purpose of pollution management. The Ajabshir plain, one of the major agricultural areas in the northwest of Iran, is always prone to pollution. Therefore, to prevent the increase in pollution, it is necessary to determine the polluting factors and areas prone to groundwater pollution. In this study, by modifying the DRASTIC method using the land-use layer, called DRASTICL, vulnerable areas and pollution index were mapped. To ensure dealing with the uncertainty of the parameters, the DRASTICL model was optimized utilizing the Sugeno-type fuzzy inference system. The models were validated based on nitrate pollution. The correlation of DRASTICL and its optimized model with the nitrate pollution are 0.32 and 0.8, respectively. The results of this study show that integrating the DRASTIC model and fuzzy knowledge is an instrumental way for assessment of vulnerability potential.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app